Share on StockTwits

CSL Limited (ASX:CSL)‘s stock had its “hold” rating reiterated by research analysts at Deutsche Bank in a report released on Tuesday, Stock Ratings News reports. They currently have a $73.20 price target on the stock.

CSL has been the subject of a number of other recent research reports. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of CSL Limited in a research note on Tuesday, April 8th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company. CSL Limited currently has an average rating of “Hold” and an average target price of A$73.18 ($67.76).

CSL Limited (ASX:CSL) traded up 0.88% on Tuesday, hitting A$68.530. 360,340 shares of the company’s stock traded hands. CSL Limited has a 52 week low of A$56.150 and a 52 week high of A$72.820. The stock has a 50-day moving average of A$70.32 and a 200-day moving average of A$68.80. The company has a market cap of A$33.176 billion and a P/E ratio of 26.99.

CSL Limited is an Australia-based company. The Company is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.